ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 34.95% | -29.10% | -54.00% | -63.28% | -51.00% |
| Gross Profit | -34.95% | 29.10% | 54.00% | 63.28% | 51.00% |
| SG&A Expenses | -57.84% | -10.29% | -18.79% | 0.85% | -8.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.56% | -22.27% | -43.06% | -46.21% | -38.20% |
| Operating Income | 6.56% | 22.27% | 43.06% | 46.21% | 38.20% |
| Income Before Tax | 121.03% | 96.67% | 40.47% | 43.19% | 26.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 121.03% | 96.67% | 40.47% | 43.19% | 26.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 121.03% | 96.67% | 40.47% | 43.19% | 26.85% |
| EBIT | 6.56% | 22.27% | 43.06% | 46.21% | 38.20% |
| EBITDA | 6.57% | 22.43% | 43.17% | 46.30% | 38.26% |
| EPS Basic | 98.64% | 89.87% | 72.72% | 68.71% | 48.32% |
| Normalized Basic EPS | 106.86% | 89.87% | 72.71% | 70.28% | 51.21% |
| EPS Diluted | 98.64% | 89.87% | 72.72% | 68.71% | 48.32% |
| Normalized Diluted EPS | 106.83% | 89.84% | 72.71% | 70.28% | 51.21% |
| Average Basic Shares Outstanding | 112.05% | 134.27% | 117.41% | 91.34% | 63.66% |
| Average Diluted Shares Outstanding | 112.14% | 134.39% | 117.41% | 91.34% | 63.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |